GlassScriptPhysician profile
Josef J Vanek
NPI 1679662373
$2,215.95
in general payments reported to CMS, 2019-2025
16 companies · $1,575 in 2025
The $1,575 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $176 · 2021: $106 · 2023: $130 · 2024: $72.33 · 2025: $1,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,055 · Food and Beverage: $701 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,055.46 |
| Food and Beverage | $701.01 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,396.82 | 2025 | |
| Bard Peripheral Vascular, INC. | $231.08 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $124.20 | 2019 | |
| Prytime Medical Devices, INC. | $111.94 | 2025 | Er-Reboa Plus |
| Ethicon US, LLC | $96.73 | 2023-2025 | Vistaseal, Evarrest, Harmonic |
| Acelrx Pharmaceuticals, INC. | $29.70 | 2019-2021 | |
| Lemaitre Vascular, INC. | $28.50 | 2023 | Artegraft Vascular Graft |
| Organogenesis INC. | $27.27 | 2023 | Puraply |
| Surmodics, INC. | $26.15 | 2024 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Novartis Pharmaceuticals Corporation | $23.32 | 2024 | |
| Davol INC. | $22.88 | 2023 | Arista Ah Flexitip |
| W. L. Gore & Associates, INC. | $22.86 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Boston Scientific Corporation | $22.23 | 2021 | |
| Csl Behring | $20.00 | 2023 | Kcentra |
| Ge Healthcare | $17.56 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josef Vanek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.